Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M150Revenue $M45.7Net Margin (%)-45.3Altman Z-Score2.5
Enterprise Value $M102EPS $-0.1Operating Margin %-44.8Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.0Pre-tax Margin (%)-44.9Higher ROA y-yY
Price/Book2.210-y EBITDA Growth Rate %-0.5Quick Ratio3.6Cash flow > EarningsN
Price/Sales3.15-y EBITDA Growth Rate %28.7Current Ratio3.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-26.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-35.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M155ROIC % (ttm)-126.1Gross Margin Increase y-yN

Gurus Latest Trades with ATRS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ATRSFirst Eagle Investment 2012-06-30 Sold Out $2.72 - $3.71
($3.13)
$ 0.97-69%Sold Out0
ATRSFirst Eagle Investment 2010-06-30 Buy $1.48 - $1.95
($1.66)
$ 0.97-42%New holding20,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ATRS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ATRS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GRAHAM PETER JSVP General Counsel, Secretary 2016-03-21Buy20,000$0.7725.97view
APPLE ROBERT FPresident & CEO 2016-03-18Buy60,000$0.7234.72view
GUETH ANTONDirector 2016-03-18Buy50,000$0.7234.72view
Fickenscher James ESenior Vice President & CFO 2016-03-18Buy135,000$0.7234.72view
JACOB LEONARD SDirector 2016-03-18Buy50,000$0.7234.72view
GONELLA JACQUESDirector 2016-03-18Buy100,000$0.7234.72view
GARRITY THOMAS JDirector 2016-03-18Buy30,000$0.7234.72view
SAMSON MARVINDirector 2016-03-18Buy50,000$0.7234.72view
ROCHE ROBERT P JRDirector 2016-03-18Buy50,000$0.7234.72view
Flynn James E 2015-09-30Sell1,828,529$1.79-45.81view

Quarterly/Annual Reports about ATRS:

News about ATRS:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BioDelivery Sciences International, TheStreet, Antares Pharma Mar 27 2016 
Weekly CFO Sells Highlight: ATRS, DENN, TTWO, JAH, ACET Jun 11 2013 

More From Other Websites
AMAG (AMAG) Q1 Earnings Beat Estimates, Keeps 2016 View May 04 2016
Antares Pharma To Host First Quarter Operating And Financial Results Conference Call May 02 2016
Antares Pharma to Present at the Deutsche Bank Securities,INC 41st Annual Healthcare Conference Apr 27 2016
Antares Pharma to Present at the Deutsche Bank Securities, Inc. 41st Annual Health Care Conference Apr 27 2016
OTREXUP.COM Website Awarded a Bronze Horizon Interactive Award Apr 25 2016
4 Trending Small Cap Stocks Making Big Moves Today Apr 22 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Apr 15 2016
New Strong Sell Stocks for April 6th Apr 06 2016
Antares Pharma Discloses Pen 1 Development Project as Teriparatide Apr 05 2016
Antares Pharma Discloses “Pen 1” Development Project as Teriparatide Apr 05 2016
New Strong Sell Stocks for March 31st Mar 31 2016
Additional Dosage Strengths of Otrexup™ (methotrexate) Injection Approved by FDA Mar 29 2016
Weekly CFO Buys Highlight: BioDelivery Sciences International, TheStreet, Antares Pharma Mar 27 2016
Five Penny Stocks To Buy Based on Smart Money Sentiment Mar 26 2016
OraSure Technologies Appoints Eamonn P. Hobbs to its Board of Directors Mar 23 2016
Falling Earnings Estimates Signal Weakness Ahead for Antares Pharma (ATRS) Mar 18 2016
Antares Pharma Announces Completion of the 52 Week QuickShot® Phase 3 Study in Testosterone... Mar 16 2016
ANTARES PHARMA, INC. Financials Mar 12 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers Mar 10 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Mar 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)